Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
Rômulo S. Cavalcante, Uta Ishikawa, Emanuell S. Silva, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 11, pp. 2284-2304
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Yunzhou Pu, Qing Ji
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 178
Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer
Maoyu Xiao, Jun He, Liyang Yin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 16
Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy
Yuanyuan He, Raimundo Fernandes de Araújo Júnior, Luis J. Cruz, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1670-1670
Open Access | Times Cited: 50
Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy
Giovanna C. N. B. Lôbo, Karen L. R. Paiva, Ana Luísa G. Silva, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1167-1167
Open Access | Times Cited: 43
Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells
Shahang Luo, Guanghui Yang, Peng Ye, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 850-850
Open Access | Times Cited: 35
Rhodiola rosea polysaccharides-based nanoparticles loaded with DOX boosts chemo-immunotherapy for triple-negative breast cancer by re-educating Tumor-associated macrophages
Yingxia Xiong, Nan Li, Miaomiao Han, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124110-124110
Closed Access | Times Cited: 22
Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway
Rui He, Yan He, Ran Du, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115090-115090
Open Access | Times Cited: 22
Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors
Anas Ahmad, Summya Rashid, Anis Ahmad Chaudhary, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 38-60
Closed Access | Times Cited: 21
Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3/NF-kB/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea
Thaís Gomes de Carvalho, Pablo Lara, Carla Jorquera-Cordero, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115663-115663
Open Access | Times Cited: 17
Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy
Wei Xiao, Jing Wang, Min Liang, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7821-7852
Open Access | Times Cited: 27
Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems
Cuiping Zhan, Ying Jin, Xinzhi Xu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11049-11072
Open Access | Times Cited: 15
Polarization of M2 Tumor-associated Macrophages (TAMs) in Cancer Immunotherapy
Indy Bui, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 75-95
Closed Access | Times Cited: 5
Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
Elisha Hayden, Holly Holliday, Rebecca Lehmann, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6251-6251
Open Access | Times Cited: 32
Nanoparticles to Target and Treat Macrophages: The Ockham’s Concept?
Mireia Medrano-Bosch, Alazne Moreno-Lanceta, Pedro Melgar‐Lesmes
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1340-1340
Open Access | Times Cited: 26
PLGA-based drug delivery system for combined therapy of cancer: research progress
Ruirui Zhang, Jian He, Ximei Xu, et al.
Materials Research Express (2021) Vol. 8, Iss. 12, pp. 122002-122002
Open Access | Times Cited: 24
Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer
Carla Jorquera-Cordero, Pablo Lara, Luis J. Cruz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 19
Hydroethanolic extract of Spondias mombin L. leaves attenuates alveolar bone loss and inflammation in a model of periodontitis induced in male Wistar rats
Ana Beatriz Costa Almeida, Agnes Andrade Martins, Susana Barbosa Ribeiro, et al.
Archives of Oral Biology (2025), pp. 106249-106249
Closed Access
Gold Nanoparticles (AuNPs) Coadministered with a β-Blocker Prevent Liver Fibrosis Caused by Ethanol and Methamphetamine in Rats by Downregulating the Expression of M2 Macrophages
Vinícius Barreto Garcia, Luiz H. S. Gasparotto, Aurigena Antunes de Araújo, et al.
ACS Omega (2025)
Open Access
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13050-13050
Open Access | Times Cited: 16
Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 3
High M2-TAM Infiltration and STAT3/NF-κB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer
George A. Lira, Fábio Mícolis de Azevedo, Ingrid Lins, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2496-2496
Open Access | Times Cited: 3
Tumor-associated macrophages within the immunological milieu: an emerging focal point for therapeutic intervention
Yanchi Shao, Song‐Hee Han, Zhenxin Hou, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36839-e36839
Open Access | Times Cited: 3
Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer
Hajime Shinohara, Maki Kobayashi, Kumiko Hayashi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13235-13235
Open Access | Times Cited: 13
A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer
Gürcan Tunalı, Hamdullah Yanık, Süleyman Can Öztürk, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top